First Report of Trametinib-Nintedanib Combination in KRAS G12D-Mutated Pancreatic Cancer: Efficacy and Fatal Hemorrhagic Complication: A Case Report.

Clin Case Rep · 2025 · PMC12657116 · PMID 41321873

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The patient's condition was stable and showed a trend toward remission, as evidenced by improvements in clinical symptoms, radiological stabilization/reduction of lesions, and a significant decline in the tumor marker CA19‐9.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.